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Permeation studyAbstract Zinc glycerolate, has been reported to be beneficial in the treatment of many medical ail-
ments but its properties for skincare application are not explored. Zinc glycerolate has been success-
fully synthesized by heating zinc oxide and glycerol in 240 C via microwave irradiation. The
characterization and properties of zinc glycerolate were discussed including scanning electron micro-
scopy (SEM), laser diffraction particle size analysis, in vitro irritancy potential, UV protection,
antibacterial and permeation properties via Franz diffusion cell of the zinc glycerolate. Zinc glycero-
late is classified as non-irritantwhenused in dermal application. It has SPFof 1.007 ± 0.004 andultra-
violet A to B (UVA/UVB) ratio of 0.7 ± 0.019 which is considered good for UVA protection under
Boot’s star rating. The antimicrobial properties of zinc glycerolate were expressed as the minimum
inhibitory concentration (MIC); theminimum bactericidal concentration (MBC) and the time needed
to eliminate 99.9% of the bacteria population (time-kill). Zinc glycerolate has better bactericidal
properties than zinc oxide particularly towards Staphylococcus epidermis, Staphylococcus aureus,
Escherichia coli, Pseudomonas aeruginosa and Propionibacterium acnes while no effect was observed
for Candida albicans and Aspergillus niger. The concentration of zinc ions that has diffused through
polysulfonemembrane installed in a vertical diffusion cell was determined through atomic absorption
spectroscopy (AAS). The highest concentration of zinc ion diffused was found from incorporation of
zinc glycerolate in oil-in-water (O/W) cream-based excipient. The obtained results indicated that zinc
glycerolate has a good potential for applications in the cosmetics and pharmaceutical products.
 2015 King Saud University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Crystalline metal complexes can be formed by heating certain
metal oxides, hydroxides or salt with glycerol at temperature
above 110 C. The metals include cobalt, iron, aluminiumn study,
2 M.Y. Cheong et al.substituted iron, manganese and zinc [1–7]. Likewise, zinc glyc-
erolate is formed by heating zinc oxide, zinc acetate or zinc
hyrozincite with glycerol from 110 to 300 C by conventional
heating or microwave irradiation [8–15]. The empirical formula
for zinc glycerolate complex is (C3H6O3Zn)x [8]. It is proposed
in a myriad of applications from cosmetics [8], nutrition as diet-
ary supplement [9,16] to bonding agent in plastic or rubber
materials [10]; but most notably in pharmaceutical [8,9,18–21].
Zinc is known as essential dietary micronutrient with benefi-
cial functions that facilitate cytoprotection and tissue repair in
humans [22]. Subcutaneous, percutaneous and intramuscular
deposition of zinc glycerolate are useful in the treatment of local
skin disorders [8,16], zinc deficiency [16], systemic inflammatory
diseases like arthritis [16,17], oral herpetic sores [18], while oral
administration of this complex aids the healing of gastric ulcers
(gastroprotective agent) [9,16] and diabetes [19–21].
The potential applications of zinc glycerolate in cosmetics
were suggested but very much less explored. Application of zinc
glycerolate can be quite similar to zinc oxide. It can be physically
retained on the skin healing withminimal or no skin irritation to
provide antioxidant photoprotection to the skin [23], protect the
skin against UV-induced skin damage, such as sunburn, cancer,
premature ageing, photoallergies [8] and prevent microbial
proliferation [9]. Its antimicrobial activities are similar with
other zinc complexes such as zinc chloride, zinc oxide, zinc
acetate, zinc phosphate and zinc polycarboxylate [24–41].
Therefore, we envisaged that zinc glycerolate is able to exert
its antimicrobial properties by liberation of Zn2+ by hydrolysis.
In our previous work, we have synthesized and character-
ized the physical properties of zinc glycerolate. We found that
zinc glycerolate hydrolyses easily in aqueous condition and can
be minimized by incorporation of zinc glycerolate with 6.5 M
glycerol solution [42].
The aim of this work is mainly to evaluate the biological
properties of zinc glycerolate and assess the feasibility of using
the complex in the cosmetics and personal care. The dermal
irritancy potential of zinc glycerolate was established by
in vitro methodology while the sun protection factor (SPF)
was determined via an ultraviolet transmittance analyser.
The antimicrobial activity of the zinc complex was determined
by a susceptibility test, MIC, MBC and a time kill study. Zinc
glycerolate in cream was used in Franz-type diffusion cells with
polysulfone membrane as a model to assess the bioavailability
of zinc ions into the human epidermis.2. Experimental
2.1. Chemicals and reagents
Zinc oxide (ZnO) is the most notable of zinc derivatives and is
widely used in cosmetics as a sunscreen agent hence will be
used as the benchmark in this study. Zinc oxide supplied as
zinkoxid reinst (ZnO) was obtained from Merck (Darmstadt,
Germany) while vegetable oil based glycerine (PricerineTM
9091) were obtained from Croda Inc. Acetone was obtained
from J.T. Baker (U. S. A.) to be used in the purification of
the samples. All other reagents were of analytical grades and
used as received.
CrodacolTM CS90EP, CrodamolTM GTCC, CrodamolTM
IPM, ArlacelTM 165, CithrolTM GMS 40 and PricerineTM 9091
were obtained from Croda International Plc (UK) whilePlease cite this article in press as: M.Y. Cheong et al., Preparation and characterizati
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stedt, Germany). Petrolatum (Vaseline) was purchased from
Sigma–Aldrich.
2.2. Bacterial strains and medium
The modified susceptibility test, minimum bacterial concentra-
tion evaluation and time kill study utilized Mueller–Hinton
agar which was obtained from Oxoid (U. K.). Sabaroud dex-
trose agar (SDA), Mueller–Hinton broth and potato dextrose
broth were purchased from Difco (U. S. A.). American Type
Culture Collection (ATCC) bacterial strains used were Staphy-
lococcus aureus ATCC 6538, Escherichia coli ATCC 8739,
Pseudomonas aeruginosa ATCC 15442, Candida albicans
ATCC 10231, Aspergillus niger ATCC 9642, Staphylococcus
epidermis ATCC 12228 and Propionibacterium acnes (clinical
isolates obtained from the Culture Collection Centre, Bacteri-
ology Unit, Institute for Medical Research, Malaysia).
2.3. Preparation and characterization of zinc glycerolate
Zinc oxide and glycerol at a molar ratio of 1:3 were heated
with frequent agitation using an Ethos MR Microwave Reac-
tor (Milestone, Germany). The initial duration of heating and
the temperature was set at 10 min and 40 C, respectively. The
optimum temperature was set at 250 C and the retention time
at this temperature was varied from 20 min to 1 h. The venting
time was set at 10 min. The reaction mixture was left to cool
and later purified using acetone. The slurry was filtered using
a Buchner funnel lined with filter paper No. 1. The sample
was dried in an oven at 90 C for 20 min. The morphology
of the zinc glycerolate particles were scanned by a Philips
XL30 scanning electron microscope. The particle size of dis-
persed zinc glycerolate was obtained by laser diffraction size
analysis using a Malvern Mastersizer Hydro 2000S particle size
analyser. The result of particle size was taken in triplicate.
2.4. In vitro dermal irritection
All potential cosmetics ingredient must be tested to ensure no
skin irritation when used. The principle of the testing is as fol-
lows: dermal irritancy induced by any substance or ingredient
is related to its ability to denature and disrupt corneal proteins
or alter the structure of keratin, collagen and other dermal
proteins. The dermal irritection assay [43], an alternative
method to animal irritancy tests or Draize test, correlates well
with in vivo irritancy tests [44]. The dermal irritection assay kit
from in vitro International is used as supplied. The dermal irri-
tection assay requires two components: a membrane substrate
modified by covalently cross linking a mixture of keratin, col-
lagen and an indicator dye, and a reagent solution consisting
of an organized globulin/protein matrix. Application of an
irritant chemical to the membrane disc disrupts the ordered
structure of keratin and collagen and results in release of the
bound indicator dye. Additionally, dermal irritants induce
conformation changes in the globular proteins found in the
reagent solution. The extent of dye release and protein denat-
uration may be quantitated by measuring the changes in opti-
cal density of the reagent solution at 450 nm (OD450).
Comparison of optical density to those produced by standard
chemical irritants and those produced by the test materialon of zinc glycerolate: UV protection, biological activity and permeation study,
2
Table 1 Classification of human irritancy equivalent (HIE)
score to predicted in vivo irritancy dermal [43].
Human irritancy
equivalent
Predicted dermal irritancy
classification
0–0.90 Non-irritant
0.90–1.20 Non-irritant/irritant
1.20–5.00 Irritant
Table 2 The Boots star rating and classification for UVA
protection is determined from the measured UVA to UVB
ratios [45].
UVA Ratio Star category Category descriptor
0.0 to < 0.2 * Too low for UVA claim
0.2 to < 0.4 ** Moderate
0.4 to < 0.6 *** Good
0.6 to < 0.8 **** Superior
P0.8 ***** Ultra
The star category denotes the protection level of the sunscreen. It
was first developed by Boots and known as Boots Star Rating
System.
Preparation and characterization of zinc glycerolate 3permits calculation of an irritancy score that has been shown
to be directly related to the dermal irritancy of the test mate-
rial. The dermal irritancy potential is expressed as the human
irritancy equivalent (HIE) scores. The predicted in vivo classi-
fications based on these scoring systems are shown in Table 1.
Samples were made up at five different concentrations: 25,
50, 75, 100 and 125 mg. These were placed into the membrane
discs. Reagent and blanking buffer (1250 lL) were added to a
24-well assay plate. The membrane discs that contained vari-
ous concentrations of zinc glycerolate samples were inserted
into the corresponding blank and test sample wells of the plate.
The assay plate was then incubated at 25 C for 24 h. The
membrane discs were then removed from the assay plate, sub-
sequently 250 lL of reagent and blanking buffer were trans-
ferred into the 96-well reading plate. The plate was then
inserted into the MRX Microplate Reader from Dynex Tech-
nologies, Inc. (Chantilly, VA).
2.5. In vitro SPF
A Labsphere Ultraviolet Transmittance Analyzer UV-1000S
was used to evaluate the in vitro SPF value of zinc glycerolate
based on their recommended procedure in line with ISO 24443
[45]. 3M TransporeTM tape was used as the substrate for in vitro
SPF measurement because of its transparency to the ultraviolet
light. 3M TransporeTM tape was placed in a single layer on a
clean 2 mm thick quartz slides. An area of at least two square
inches (12.5 cm2) was used to enable measurement over at least
five non-overlapping spots. Samples of 5.0%, 10.0% and
20.0% of zinc glycerolate, titanium dioxide or zinc oxide were
prepared by mixing with glycerol to form a paste. About
2.0 mg/cm2 samples were distributed evenly over the entire sur-
face of the sample plate. The samples were put aside to dry for
at least 20 min before measurements were made. Twelve read-
ings were taken for each sample. The testing of samples was
performed by running a baseline on the reference media of
glycerol before the prepared samples were analysed.
SPF by definition is determined in vivo as the increase in
exposure time required to induce erythema. However, the
in vitro technique involves measuring the spectral transmit-
tance at UV wavelengths from 280 nm to 400 nm. The
in vitro SPF is calculated based on Eq. (1):
SPF ¼
R 400nm
280nm
Ek:Skdk
R 400nm
280nm
Ek:Sk:Tk:dk
ð1Þ
where, Ek =CIE erythemal spectral effectiveness, Sk = solar
spectral irradiance, Tk = spectral transmittance on the sample
(as measured on the UV-1000S).
The equation shows that the higher the amount of transmit-
tance, the lower the SPF value. The transmittance spectrum of
a sunscreen in either region is averaged in order to produce a
single value, which describes the amount of UV-A or UV-B
blocking. The average transmittance in each region is given
by Eqs. (2) and (3) respectively:
TðUVAÞav ¼
P400nm
315nmTkDkP400nm
315nmDk
ð2Þ
and
TðUVBÞav ¼
P315nm
280nmTkDkP315nm
280nmDk
ð3Þ
where, Dk =measured wavelength interval.Please cite this article in press as: M.Y. Cheong et al., Preparation and characterizati
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respectively, is calculated as in Eq. (4);
100% TðUVAÞav or 100% TðUVBÞav ð4Þ
where, T(UVA)av or T(UVB)av are expressed as a percentage.
In addition to its ability to determine the SPF of a sun-
screen, the in vitro technique can also measure the UVA pro-
tection of the sunscreen. Boots the Chemist, the largest
producer of sunscreens in the UK, has developed a label sys-
tem that uses star ratings for protection based on spectropho-
tometric analysis. The Boots star rating system is a proprietary
in vitro method used to describe the ratio of UVA to UVB pro-
tection offered by sunscreen creams and sprays as classified in
Table 2.
The spectral transmittance values, Tk, are converted to
spectral absorbance values, Ak = log(Tk). A term called the
UVA ratio is calculated, which is the ratio of the total
absorption in the UVA to that in the UVB as in Eq. (5).
aUVA
aUVB
¼
R 400nm
280nm
Akdk
R 320nm
290nm
Ak:dk
ð5Þ
2.6. Susceptibility testing
In order to test the zinc glycerolate which is an insoluble pow-
der in water, a modified Kirby–Bauer method was used for
susceptibility testing [46]. The modification consisted of utiliz-
ing a sterile, stainless steel cork-borer with circular diameter of
5 mm to bore sample wells on Mueller–Hinton agar that had
been swiped three times with a 0.5 McFarland standard sus-
pension of microorganisms with sterile cotton buds. The wells
were sealed with one drop of sterile molten agar to prevent
leakage from the base of the seeded culture plates. The follow-
ing monoculture strains have been used for streaking the sur-
face of Mueller–Hinton agar: S. aureus, E. coli, P.
aeruginosa, C. albicans, A. niger, S. epidermis and P. acnes.
All the aerobic bacteria were grown to confluence on Muel-
ler–Hinton agar (Oxoid) for 24 h at 36 C and harvested intoon of zinc glycerolate: UV protection, biological activity and permeation study,
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4 M.Y. Cheong et al.0.9% sterile saline solution except C. albicans and A. niger
which were grown to confluence on SDA for 72 h at 25 C.
P. acnes was grown at Columbia sheep blood agar in an anaer-
obic jar with anaerobic atmosphere generation bags for 24 h at
36 C. Samples were harvested into 0.9% sterile saline solution
and then standardized to 108 colony forming units (CFU) per
millilitre by turbidity or equivalent to a 0.5 McFarland turbid-
ity standard. It was verified by a UV–VIS spectrophotometer
at an optical density of 600 nm absorbance of approximately
0.08 0.10. For A. niger, a haemocytometer was used to adjust
the density of spores to 1  108 CFU/mL.
Approximately 0.01 g of sample was placed in the cut-out
sample wells. The agar plates were incubated at 36 C for
24 h for aerobic bacteria and anaerobically for P. acnes. The
incubation condition for C. albicans and A. niger was 25 C
for 72 h. The diameter of the zone of inhibition of the samples
tested was compared with a 10 lg streptomycin disc for bacte-
ria and 10 lg miconazole for C. albicans and A. niger.
2.7. MIC and MBC determination
A macrodilution susceptibility testing method was used to
determine the minimal concentration of antimicrobial agent
needed to inhibit or kill S. aureus, E. coli, P. aeruginosa, C.
albicans, A. niger and S. epidermis [47]. Zinc glycerolate, from
0.01 g to 0.20 g in 0.01 g increments, was placed in sterile test
tubes and then 1.8 mL of sterile Mueller–Hinton broth was
placed into the test tubes with 0.2 mL of standardized 0.5
McFarland suspensions of bacteria. The same procedure was
repeated for C. albicans and A. niger except Mueller–Hinton
broth was replaced by potato dextrose broth. For A. niger, a
haemocytometer was used to adjust the density of spores to
1  108 CFU/mL. The broth was inoculated to a final cell den-
sity of 1  106 CFU/mL. The test tubes were incubated at
36 C for 24 h for bacteria or at 25 C for 72 h for C. albicans
and A. niger. After incubation, the lowest concentration of zinc
glycerolate showing no visible growth was considered as the
MIC [47]. MBC was determined by pipetting 0.1 mL of the
inoculated Mueller–Hinton or potato dextrose broth onto
Mueller–Hinton agar for bacteria or SDA for yeast and fungi.
The plates were then incubated at 36 C for 24 h for bacteria or
25 C for 72 h for C. albicans and A. niger. Colony counts were
made after incubation and the surviving colonies were com-
pared to the starting inoculum. The lowest concentration of
sample required to kill 99.9% the tested microorganism was
recorded as MBC. If the material being tested is bacteriostatic,
there will be bacterial colonies observed upon incubation after
plating while no positive growth will be seen if the material is
bactericidal. The same principal applied to yeast and fungi to
establish if the material is fungicide or fungistatic [41].
2.8. Time-kill study
The time kills study was done in a manner as described [48].
The selected bacteria, yeast and fungi strains used in the study
were S. aureus, E. coli, P. aeruginosa, C. albicans, A. niger and
S. epidermis. A 0.1 mL suspension of bacteria was standardized
to 0.5 McFarland and inoculated in 0.9 mL Mueller–Hinton
broth supplemented with 0.05 g zinc glycerolate so that
the broth was inoculated to a final cell density of
1  106 CFU/mL Aliquots of 0.1 mL were taken at hourlyPlease cite this article in press as: M.Y. Cheong et al., Preparation and characterizati
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incubated at 37 C for 24 h to determine total viable counts.
The same procedure was repeated for yeast and fungi strains
by replacing Mueller–Hinton broth with potato dextrose broth
and SDA and incubating at 25 C for 72 h. Kill curves were
constructed by plotting log10 CFU against time. Testing for
neutralization of the sample was done to ensure no false
negative was recorded due to presence of active zinc complex
carried over from the sample into the media which may inhibit
viable microorganisms. Determination of the initial number of
viable microorganisms was done by running a control test using
sterile deionized water instead of the zinc glycerolate.
2.9. Preparation of O/W emulsion
Non-ionic O/W emulsions were prepared: zinc glycerolate
cream with 5% w/w of zinc glycerolate, zinc oxide cream with
10% w/w of zinc oxide and placebo cream. To prepare the
cream, the oily (CrodacolTM CS90EP, CrodamolTM GTCC, Cro-
damolTM IPM, ArlacelTM 165 and CithrolTM GMS 40) and aque-
ous phases (PricerineTM 9091 and deionized water) were heated
separately until reach 75 C, then the oily phase was added to
the aqueous phase and the system was mixed (Polytron,
500 rpm) with constant agitation for 5 min before stirring
was slowed to 150 rpm. Preservative (Euxyl PE 9010) and
zinc complex (zinc glycerolate or zinc oxide) were added into
the cream when the temperature reached 25 C.
2.10. Permeation study by Franz diffusion cell
The permeation of chemicals through the skin can be mea-
sured by in vitro techniques using the static, non-flowing cell
generally known as Franz diffusion cell. Permeation test
through polysulfone membrane (HT-450 Tuffryn, Pall) with
diameter of 25 mm and pore size of 0.45 lm were carried out
using a vertical diffusion cell system (Hanson Research, Chats-
worth CA, USA) consisting of six thermostated cells with the
lower donor and the upper receptor chambers separated by
membrane, the stratum corneum facing the donor chamber.
The donor compartment diameter was 15 mm, providing an
application area of 1.77 cm2. This cell has a static receptor
solution reservoir with a side-arm sampling port. Permeation
was monitored by sampling the stirred receptor chamber
solution [49]. Isotonic phosphate buffered saline pH 7.4
(PBS) was prepared by dissolving 8.00 g NaCl, 0.20 g KCl,
0.20 g KH2PO4 and 1.44 g Na2HPO42H2O in 1 L distilled
water. PBS was used as the receptor solution. The receptor
compartment was filled with 4.3 mL of PBS which was kept
at 37 C by circulating water through an external water jacket.
After 30 min of equilibration of the membrane with the
receptor solution, 3.0 g of the sample was applied in the donor
compartment. The donor compartment was covered with glass
slides to prevent evaporation of the solvent. The receptor solu-
tion was continuously stirred by means of a spinning bar mag-
net, at 400 rpm. Receptor solution samples were withdrawn as
2.0 mL aliquots, through the sampling port of the receptor
compartment at various time intervals. The experiments were
run for 6 h and were repeated three times. The concentration
of zinc ions in the receptor solution was determined by means
of atomic absorption spectroscopy (AAS) from Thermo Finni-
gan Model S4.on of zinc glycerolate: UV protection, biological activity and permeation study,
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Linear regression analysis of pseudo-steady-state diffusion
plots allowed calculation of the following parameters:
steady-state flux (J), given by Q/A.t, where Q is the amount
of permeate diffusing across the area (A) in time (t). Lag time
(tL), indicated the time taken by the sample to saturate the
membrane and to reach the receiving phase, calculated from
the X-axis intercept values of the regression lines with amount
of zinc ion permeated at end of experiment (Q60 min) is calcu-
lated. TRPE apparent diffusion coefficient through membrane
was calculated according to the following relation: Dm = h
2/6-
tL where h represents the thickness of the membrane of the
membrane and tL the lag time. The thickness of the membrane
was 145 lm, as indicated from the product specification. The
permeability coefficient, Kp was calculated using equation:
Kp = J/Co where J is the flux at steady state (mg/cm
2 min)
and Co is the initial zinc oxide or glycerolate concentration
(mg/L). Membrane/vehicle partition coefficient, Km, was
obtained from the relationship: Kp = KmDm/h [50].3. Result
3.1. Evaluation of zinc glycerolate
The SEM of zinc glycerolate and zinc oxide is given in
Fig. 1a and b, respectively. The zinc glycerolate obtained
was a random heap of hexagonal prisms with an average diam-
eter and thickness of ca. 2.5 lm and ca. 350 nm, respectively.
The average particle size by volume weighted mean, D (4,3)
of zinc glycerolate was 23.015 lm as shown in Fig. 2 while
for zinc oxide it was 12.543 lm.
3.2. Evaluation of in vitro irritection and SPF
The dose response curve of HIE scores on dermal for zinc glyc-
erolate is shown in Fig. 3. The graph indicated that even at
increasing dosage of zinc glycerolate from 50, 75, 100 to
125 lL, the results were below the threshold value of HIE
score of 0.9, hence it is classified as a non-irritant.
Attenuation spectra for 20% zinc glycerolate are shown in
Fig. 4 with UVA (320–400 nm) and UVB (290–320 nm). Fig. 5Figure 1 Scanning electron microscopy of (a) zinc glycerolate
Please cite this article in press as: M.Y. Cheong et al., Preparation and characterizati
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rating of zinc oxide, titanium dioxide and zinc glycerolate
respectively. Generally, average SPF values and UVA to
UVB ratios of all samples in glycerol increased in line with
the higher sample amount of zinc oxide, titanium dioxide
and zinc glycerolate respectively in the formulation. Zinc glyc-
erolate has the lowest SPF value, UVA/UVB ratio and Boots
star rating as compared to zinc oxide and titanium dioxide,
even at increased concentrations. However it is noted that
the Boots star rating of 20% zinc glycerolate is comparable
to 5% titanium dioxide. At 5% concentration, zinc glycerolate
has a mean SPF of 1.07 ± 0.004 and a UVA/UVB ratio of 0.7
± 0.019, which is considered ‘good’ (three stars) under the
Boots star rating for UVA protection. Comparatively, the
SPF value of 5% titanium dioxide is 1.33 ± 0.005, the
UVA/UVB ratio is 0.85 ± 0.036 and has a ‘superior’ Boots
star rating (four stars). The SPF value of 5% zinc oxide is
1.36 ± 0.05, the UVA/UVB ratio is 0.91 ± 0.023 and has an
‘ultra’ Boots star rating (five stars).
3.3. Evaluation of antimicrobial activity
Fig. 6 shows the zone of inhibition around the 6 mm diameter
wells made by the cork-borer filled with 10 lg zinc glycerolate
or zinc oxide and 10 lg of streptomycin disc of 6 mm diameter.
The diameter of the zones of inhibition recorded in Fig. 7 for
bacteria and Fig. 8 for yeast and mould. There were positive
zones of inhibition for S. aureus, E. coli, S. epidermis, P. acnes,
C. albicans and A. niger while no inhibitory activity were
recorded for P. aeruginosa.
The results of susceptibility tests with zinc glycerolate
against reference strains are summarized in Table 3. The
MIC50s and MIC90s were in the range of 5 mg/mL for
S. epidermis and S. aureus while for E. coli and P. aeruginosa
it is 10 mg/mL. The MIC50s in the range of 10 mg/mL for both
C. albicans and A. niger while MIC90s value ranges from 10 to
30 mg/mL for C. albicans and A. niger respectively. The MBCs
were in the range of 5.0–15 mg/mL for bacteria. It was noted
that optimum inhibition power of 99.9% population wipeout
or MBC was exhibited at 5.0 mg/mL for S. epidermis and
S. aureus while 15.0 mg/mL for E. coli and P. aeruginosa.
Positive growth was observed for C. albicans and A. niger
when the broth was pipetted out and set into agar.magnified to 3000 and (b) zinc oxide magnified to 7500.
on of zinc glycerolate: UV protection, biological activity and permeation study,
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Figure 2 Size distribution of zinc glycerolate particles.
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Figure 3 Dose–response curve for HIE score on dermal for zinc glycerolate. The data represent ±SD of three replicates.
6 M.Y. Cheong et al.As further extension of the MIC and MBC, time kill stud-
ies were initiated. Fig. 9(a–d) demonstrate time-dependent
microbicidal action of zinc glycerolate at 50.0 mg/mL, which
is slightly higher than the minimum MBC needed to inacti-
vate P. aeruginosa. The slope of the line of regression (K)
could be used for the analysis of bactericidal activity of zinc
glycerolate against different microbial species [48]. From the
analysis of kill curve the time required to achieve 1 log10
reduction (90%) or 3 log10 reduction (99.9%) decrease in
viable cell count was calculated (Table 4). Data in Table IV
show that the time required to achieve a 1 log10 reduction
(90%) in all tested strains (except for yeast and fungi) ranged
within 1.19–2.81 h. In general, Gram-positive bacteria were at
the lower end and Gram-negative bacteria were at the higher
end of reduction range indicating Gram-positive bacteria
were killed faster than Gram-negative bacteria. Also, at lower
absolute values of K, the bactericidal activity was found to bePlease cite this article in press as: M.Y. Cheong et al., Preparation and characterizati
Journal of Saudi Chemical Society (2015), http://dx.doi.org/10.1016/j.jscs.2015.09.00greater [48]. Among all the strains tested Gram-positive bac-
teria such as S. aureus and S. epidermis were found to be the
most susceptible to zinc glycerolate as 90% of the population
were inhibited in the least time in about 1.19 h while Gram-
negative bacteria such as E. coli and P. aeruginosa were
inhibited in 1.58 and 2.81 h respectively. The time required
to achieve 3 log10 decreases in viability was also determined
from the time kill curves at 50.0 mg/mL zinc glycerolate.
Once again, zinc glycerolate kills Gram-positive bacteria
more effectively, achieving a 3 log10 decrease in 3.57 and
3.68 h for S. epidermis and S. aureus respectively versus
4.74 and 8.42 h killing time for E. coli and P. aeruginosa
respectively. There was no growth seen after incubation of
8 and 24 h for the tested microorganism when plating out
was done except for C. albicans and A. niger which showed
positive growth. Neutralization studies done on all diluted
plates indicated no false negatives.on of zinc glycerolate: UV protection, biological activity and permeation study,
2
Figure 4 Attenuation spectra for 20% zinc glycerolate in glycerol. Twelve scans were made for each sample.
Preparation and characterization of zinc glycerolate 73.4. Evaluation of zinc permeation
The ability of zinc ions to permeate the human skin as mod-
elled using a polysulfone membrane with PBS as the receptor
solution. The samples used were 50.0 mg/mL zinc glycerolate
in petrolatum base, 50.0 mg/mL zinc oxide powder in petrola-
tum base and 50.0 mg/mL zinc glycerolate powder in cream
base which consisted of a propriety combination of medium
chain triglycerides, wax, glycerol and emulsifiers. As indicated
in Fig. 10, the highest zinc level was detected from zinc glyc-
erolate in a cream base throughout the experiment compared
to pure zinc glycerolate and zinc oxide powder.
Results of zinc ion permeation experiments are illustrated
graphically in Fig. 10, whereas the relevant permeation param-
eters (J, tL,Q60 min,Kp,Dm,Km) are summarized in Table 4. The
permeation profiles demonstrated that the incorporation of the
O/W emulsion with 5% (w/w) zinc glycerolate remarkably
increased the permeation of zinc ion through membrane. After
application of the mixture above, the steady state flux of zinc
ion through membrane was found to be 0.0017 mg cm2 min1.
The permeation of zinc from petrolatum as excipient decreased
about three times with 0.00051 lg cm2 min1 flux. In addition,
the amount of zinc ion permeated fromO/W emulsion was 1.10
± 0.08 mg cm2 compared to 0.33 ± 0.02 mg cm2 obtained
from 5% (w/w) zinc glycerolate in petrolatum mixture. In all
cases, the differences were statistically significant between 5%Please cite this article in press as: M.Y. Cheong et al., Preparation and characterizati
Journal of Saudi Chemical Society (2015), http://dx.doi.org/10.1016/j.jscs.2015.09.00(w/w) zinc glycerolate in two different kind of excipient; O/W
emulsion and petrolatum: P= 0.013 in the case of flux;
P= 0.036 for zinc ion permeated. It is confirmed that the
rate-limiting step was the zinc ion release from the formulation
as the water in the O/W influences the zinc ion availability for
hydrolysis. Petrolatum’s hydrophobicity which coated zinc
glycerolate and rendered insoluble with the water minimized
the hydrolysis of zinc glycerolate [50].
4. Discussion
The SEM showed the differences between zinc glycerolate and
zinc oxide. The large, plate-like and hexagonal shape of the
zinc glycerolate complex was well defined; which distinguished
it easily from the more regular and fine particulates of zinc
oxide. Zinc glycerolate which was formed had a substantially
greater development in two dimensions in one plane than in
a third dimension normal to the other plane. The lustrous,
large sized crystallite particles endowed zinc glycerolate with
a high lubricity which is an advantageous attribute for topical
dermal application [9].
Although zinc glycerolate is classified as non-irritant to
dermal application and regarded as safe for use in cosmetics
products, an in vivo study needs to be conducted to establish
its irritancy potential in human living systems. The lower
values of SPF, UVA/UVB ratio and Boots star rating of zincon of zinc glycerolate: UV protection, biological activity and permeation study,
2
Figure 5 Average SPF values, UVA to UVB ratios and Boots star rating of zinc glycerolate, titanium dioxide and zinc oxide. The data
represent ±SD of twelve scans.
a 
b
c
Figure 6 Antimicrobial susceptibility testing of zinc glycerolate
and zinc oxide with streptomycin as a control on an agar plate
swiped with S. aureus, well (a) contains 10 lg of zinc oxide, well
(b) has 10 lg of zinc glycerolate and well (c) has 10 lg of
streptomycin.
8 M.Y. Cheong et al.glycerolate as compared to zinc oxide could be attributed to the
huge size of zinc glycerolate as compared to finer particulate of
zinc oxide as per result from laser diffraction size analysis. This
could be because of the presence of trace glycerine which ren-
dered the powder sticky and hence the particulates agglomer-
ated. It is assumed that absorption, scattering and reflection
become insignificant when the size of the mineral particles
becomes coarse. Such mineral sunscreens also have poor UV
protection performance because light ‘leaks’ through the gaps
between large particles.
Positive zones of inhibition were observed for S. aureus,
E. coli, S. epidermis, P. acnes, C. albicans and A. niger in thePlease cite this article in press as: M.Y. Cheong et al., Preparation and characterizati
Journal of Saudi Chemical Society (2015), http://dx.doi.org/10.1016/j.jscs.2015.09.00susceptibility testing using a modified Kirby–Bauer method.
Though the result is positive, the size of the zone must not
be interpreted as a quantitative evaluation of antimicrobial
activity [47]. Zinc glycerolate exhibits better bacteriostatic
activity against selective bacteria and better fungistatic activity
towards yeast and mould than zinc oxide. It was also noted
that Gram-positive bacteria were susceptible while Gram-
negative bacteria were quite resistant to zinc complexes tested.
The MIC via the broth dilution method showed that zinc
glycerolate has bacteriostatic activity towards S. epidermis,
S. aureus, E. coli and P. aeruginosa while fungistatic effect
was observed for C. albicans and A. niger. However the
MBC result showed that zinc glycerolate has bactericidal activ-
ity towards S. epidermis, S. aureus, E. coli and P. aeruginosa. It
showed fungistatic activity that prevents proliferation of C.
albicans and A. niger as indicated by the MBC result. There
were no fungicidal or sporicidal effects when positive growth
of these yeast and fungi were observed when the broth was pla-
ted out [41].
In time-kill study, the decrease in viability in 8 h and no
positive growth upon continued incubation for 24 h had con-
firmed that zinc glycerolate possess bactericidal effect. The
time-kill study also reconfirmed that zinc glycerolate has fun-
gistatic activity against C. albicans and A. niger when positive
growths were observed for both yeast and fungi respectively
after the tested broth was plated out. The antimicrobial effecton of zinc glycerolate: UV protection, biological activity and permeation study,
2
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Table 3 The MIC and MBC of zinc glycerolate against
different organisms.
Organism used Zinc glycerolate (mg/mL)
MIC50
a MIC90
b MBC99.9
c
Staphylococcus epidermis ATCC
12228
5.0 5.0 5.0
Staphylococcus aureus ATCC 6538 5.0 5.0 5.0
Escherichia coli ATCC 8739 10.0 10.0 15.0
Pseudomonas aeruginosa ATCC
15442
10.0 10.0 15.0
Candida albicans ATCC 10231 10.0 10.0 ND
Aspergillus niger ATCC 9642 10.0 30.0 ND
MIC50
a : minimum inhibitory concentration required to inhibit the
growth 50% of population (scored visually after 14–16 h of incu-
bation). MIC90
b : minimum inhibitory concentration required to
inhibit the growth 90% of population (scored visually after 24 h of
incubation). MBC99.9
c : minimum bactericidal concentration
required to kill 99.9% of population (scored by spot inoculation on
Muller–Hinton agar from the wells showing no growth after 24 h).
ND: not detectable [47].
Preparation and characterization of zinc glycerolate 9of zinc glycerolate against the tested microorganisms present in
the following order:
Staphylococcus epidermis ATCC 12228 < Staphylococcus
aureus ATCC 6538 < Escherichia coli ATCC 8739 < Pseu-
domonas aeruginosa ATCC 15442
Divalent cations are essential nutrients for bacteria and are
required as trace elements at nanomolar concentrations. In
vitro bacterial growth requires zinc ion concentrations of
105–107 M for optimal growth [35]. However, at higher con-
centrations, these ions are potentially toxic. The toxicity of
heavy metals is mainly due to their interference with microbial
metabolism or their altering of the physicochemical environ-
ment of cells [51]. A concentration of 10 mM Zn2+ decreasedPlease cite this article in press as: M.Y. Cheong et al., Preparation and characterizati
Journal of Saudi Chemical Society (2015), http://dx.doi.org/10.1016/j.jscs.2015.09.00the survival of E. coli but did not affect that of P. aeruginosa
after 3 h of incubation in buffer [52].
The antibacterial activity of the Zn2+ ion could be due to
transmetallation, in which zinc glycerolate complex exchanges
zinc for other vital metals in bacterial cells [53]. Zinc
glycerolate has weak a metal-bidentate ligand bond via its
1,2-hydroxyl groups that results in fast hydrolysis of this com-
plex in aqueous conditions resulting in zinc ions and glycerol
that diffuse into the agar. The liberation of low-molecular
weight components like glycerol, zinc ions and Zn(OH)+ spe-
cies may have provided the inhabitable environment for tested
bacteria, yeast and fungi to proliferate. On the other hand, zinc
ions could be toxic to bacteria though the mechanism for the
toxicity of Zn2+ is undefined although several possible mech-
anisms have been proposed. Excess of Zn2+ may interfere with
the metabolism of Mg2+ [54,55]. Bacterial cells take in zincon of zinc glycerolate: UV protection, biological activity and permeation study,
2
Figure 9 Bactericidal activities of zinc glycerolate against time at 50.0 mg/mL with S. epidermis, S. aureus, E. coli and P. aeruginosa.
The data represent ±SD of three replicates (error bars not shown as deviations from the mean values are <0.1  log10).
10 M.Y. Cheong et al.ions, which inhibit several functions in the cell and conse-
quently damage cells. It has also been suggested that zinc binds
to the membranes of microorganisms, similar to mammalian
cell [35], prolongs the lag phase of the growth cycle and
increases the generation time of the organisms so that each
organism takes more time to complete cell division [56]. Zinc
inhibits multiple activities in the bacterial cell, such as
glycolysis, transmembrane proton translocation and acid
tolerance [57]. Furthermore, though generally regarded as
bacteriostatic, it can have bactericidal effects, particularlyPlease cite this article in press as: M.Y. Cheong et al., Preparation and characterizati
Journal of Saudi Chemical Society (2015), http://dx.doi.org/10.1016/j.jscs.2015.09.00when used in combination with other ions, such as fluoride
[58], chlorine ions [52] or antibacterial agents like
triclosan [59].
In general, Gram-positive aerobic bacteria (S. aureus and S.
epidermis) are more susceptible to zinc ions as compared to
Gram-negative aerobic bacteria (E. coli and P. aeruginosa).
Gram-positive bacteria do not have an outer membrane which
acts as a barrier whereas Gram-negative bacteria contain an
impenetrable outer membrane wall which consists of
lipopolysaccharide and protein which envelope the bacteriaon of zinc glycerolate: UV protection, biological activity and permeation study,
2
Table 4 Time-kill activity of zinc glycerolate at 50.0 mg/mL.
Organism used D at MICa (h)
a D* at MICb (h)
b
Staphylococcus epidermis ATCC 12228 1.19 3.57
Staphylococcus aureus ATCC 6538 1.23 3.68
Escherichia coli ATCC 8739 1.58 4.74
Pseudomonas aeruginosa ATCC 15442 2.81 8.42
Candida albicans ATCC 10231 ND ND
Aspergillus niger ATCC 9642 ND ND
ND= not detected [48].
a D= time required to achieve 1 log10 (90%) reduction total viable cell count.
b D= time required to achieve 3 log10 (99.9%) reduction total viable cell count.
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Figure 10 Permeation of zinc ions into PBS in Franz diffusion cell. The data represent ±SD of three replicates.
Preparation and characterization of zinc glycerolate 11[60]. On top of that, P. aeruginosa is able to produce slime
which covers itself, thus exceptionally resistant to chemical
agent [61,62]. As noted in the previous section, P. aeruginosa
has the stronger ability to proliferate and resists the activity
of zinc ions better than E. coli and this corresponded with
the result of previous research done [58]. Zn2+ is a also
micronutrient for A. niger growth [63] and for maintaining
the integrity of the cell wall of P. aeruginosa [64], hence they
were tolerant of high Zn2+ concentrations. P. aeruginosa can
survive longer in damp conditions, and also has a stronger
resistance against dryness, ultraviolet and chemical antiseptics
such as aldehyde, hydrargyrum and surface-acting agents aside
from zinc ions [65]. Heavy metal resistance in microorganisms
can occur by a variety of mechanisms, including physical
sequestration, exclusion and/or efflux, reduced uptake, detox-
ification and synthesis of binding proteins. In Pseudomonas
sp., zinc resistance is inducible. The induction of Zn2+ resis-
tance leads to enhanced accumulation of the metal by rapid
initial Zn2+ uptake followed by gradual stable phase. The
uptake of the Zn2+ triggered an internal detoxification mech-
anism that resulted in the extrusion of the excess zinc [51]. InPlease cite this article in press as: M.Y. Cheong et al., Preparation and characterizati
Journal of Saudi Chemical Society (2015), http://dx.doi.org/10.1016/j.jscs.2015.09.00comparison with other divalent heavy metals, such as Cd2+,
Pd2+, or Hg2+, a relatively high concentration of Zn2+ was
required to inhibit growth rates of fungi and to reduce survival
of bacteria. This greater tolerance to Zn2+ may have reflected
the differential sorption of Zn2+ to ionogenic sites on the sur-
face of cells [52].
Different interactions between zinc glycerolate/excipient,
excipient /membrane and zinc glycerolate/membrane may
affect the permeation. In order to assess the mechanism of
TRPE permeation through the skin, the influence of Kp, Dm
and Km was investigated particularly between excipient O/W
emulsion and petrolatum. As shown in Table 5, Dm and Km
values showed opposite trends. The data obtained pointed
out that the Dm alone could not be regarded as a predictive
parameter to evaluate zinc ion permeation through the mem-
brane because it takes into account only the lag time but not
what happens once the steady state is reached [50]. A more
complete frame could be obtained calculating the membrane/
excipient partition coefficient, Km, which was about 11-fold
higher for the zinc glycerolate with O/W emulsion than for
the zinc glycerolate with petrolatum. Hence, it was noted thaton of zinc glycerolate: UV protection, biological activity and permeation study,
2
Table 5 Permeation parameters of zinc ion from 5% zinc glycerolate in different excipients namely in O/W emulsion or petrolatum
and 5% zinc oxide in petrolatum.
Formulation J
(mg cm2 min1)
tL
(min)
Q360 min
(mg cm2)
Kp
(cm min1)
Dm
(cm2 min1)
Km
5% (w/w) zinc glycerolate in O/W
cream
0.0017 7.29 1.10 ± 0.08 3.47  108 2022480.41 2.48  1012
5% (w/w) zinc glycerolate in petrolatum 0.00051 7.20 0.33 ± 0.02 1.02  108 6849747.89 2.17  1013
5% (w/w) zinc oxide in petrolatum 0.00034 7.62 0.22 ± 0.05 6.80  109 10304138.9 9.57  1014
12 M.Y. Cheong et al.the inclusion of O/W emulsion as excipient for zinc glycerolate
has improved the permeation of zinc ion based on polysulfone
membrane model.
Zinc glycerolate has the ability to provide the skin with the
mineral zinc and it has potential bioavailability to the epider-
mis as found in the permeation study using Franz diffusion
cell. This was also observed in other study on the skin of rats
[17]. Zinc ions from the hydrolysis of zinc glycerolate from
moisture in the cream diffused into Franz diffusion cell
through polysulfone membrane.5. Conclusion
Based on these findings, zinc glycerolate has been successfully
synthesized. It can be a useful ingredient in the cosmetic and
pharmaceutical products for its low irritation to dermal, has
sun protective, bactericidal as well as fungistatic properties
and able to supplement the skin with zinc nutrient when O/
W emulsion was used as the excipient.
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